Corvus Pharmaceuticals, Inc. (CRVS) Reports In-Line Q3 EPS

Go back to Corvus Pharmaceuticals, Inc. (CRVS) Reports In-Line Q3 EPS
(NASDAQ: CRVS) Delayed: 12.71 +0.15 (1.19%)
Previous Close $12.56    52 Week High $17.77 
Open $12.10    52 Week Low $9.63 
Day High $13.07    P/E N/A 
Day Low $12.09    EPS $0.00 
Volume 678,933